deaths from glp-1 Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease GLP-1 receptor agonists' impact on

As such, the key players are erecting data walls around completed and ongoing studies, many of which are of the type that competitors have not yet even started

"But studies have found that a BMI higher than 25 increases ones risk for heart disease, type two diabetes, and some forms of cancer

Lee, M.Y

This fueled an exponential growth in interest among the public, but not everyone qualifies for GLP-1s through their insurance or can afford them, even if they do

To access these GLP-1 medications, a doctor or provider much submit a prior authorization request and a prescription for one of the eligible GLP-1 drugs